Aptamer Group PLC (AIM:APTA)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 20.73M |
| Revenue (ttm) | 1.38M |
| Net Income (ttm) | -2.46M |
| Shares Out | 3.46B |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,648,307 |
| Average Volume | 7,079,985 |
| Open | 0.589 |
| Previous Close | 0.600 |
| Day's Range | 0.565 - 0.650 |
| 52-Week Range | 0.280 - 1.570 |
| Beta | 0.90 |
| RSI | 36.32 |
| Earnings Date | Mar 30, 2026 |
About Aptamer Group
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and b... [Read more]
Financial Performance
In fiscal year 2025, Aptamer Group's revenue was 1.20 million, an increase of 39.88% compared to the previous year's 860,000. Losses were -2.42 million, -18.05% less than in 2024.
Financial StatementsNews
Half Year 2026 Aptamer Group PLC Earnings Presentation Transcript
Half Year 2026 Aptamer Group PLC Earnings Presentation Transcript
Aptamer Group: Partnership cash helping to fund development
Biotech specialist Aptamer Group says it is edging closer to commercial validation of its synthetic binder technology.
Aptamer Enters Licensing Agreement With Alphazyme
(RTTNews) - Aptamer Group (P0J.F, APTA.L) and Alphazyme, a Maravai LifeSciences (MRVI) company, have entered into a licensing agreement for a developed Optimer for use in hot-start PCR applications. A...
Full Year 2025 Aptamer Group PLC Earnings Presentation Transcript
Full Year 2025 Aptamer Group PLC Earnings Presentation Transcript
AIM Market Roundup: HSS Hire, Aptamer, EQTEC
HSS Hire, Aptamer, EQTEC are today's top risers, while tinyBuild, MediaZest take the biggest fall on London's AIM market
Aptamer Group launches biomarker discovery service to expand revenue base
Aptamer Group has unveiled a new biomarker discovery service as part of efforts to broaden its revenue streams.
UK Stock Market News: Aptamer, MicroSalt, HICL
Contract extension with major pharma for Aptamer, MicroSalt sees FDA delays drag on sales outlook, £225m disposal at HICL
AIM Market Roundup: Westmount Energy, Aptamer, Europa Oil & Gas
Westmount Energy, Aptamer, Europa Oil & Gas are today's top risers, while Tasty, Mothercare take the biggest fall on London's AIM market
Half Year 2025 Aptamer Group PLC Earnings Presentation Transcript
Half Year 2025 Aptamer Group PLC Earnings Presentation Transcript